Kyrgyz Republic Tuberculosis Roadmap Overview, Fiscal Year 2021

Speeches Shim

This is an overview of the USAID/Kyrgyz Republic FY 2021 Tuberculosis (TB) Roadmap, implemented with FY 2020 budget. It was developed in consultation with the National TB Program (NTP) and with the participation of national and international partners involved in TB prevention and care in the country.

The Kyrgyz Republic is among the high multidrug-resistant TB (MDR-TB) burden countries. The country has an estimated TB burden of 7,1002 and detected 6,138 (87 percent) individuals with TB. Additionally, the MDR-TB and extensively drug-resistant TB (XDR-TB) burden has been increasing with 1,577 registered cases in 2019 alone. The estimated proportion of MDR-TB among new cases is 29 percent, and among the retreatment cases it is 60 percent.

In 2017, the Kyrgyz Republic adopted the National TB Strategy for 2017-2021 as a guiding document for planning and implementing TB control activities nationwide. The Ministry of Health (MOH) and NTP are currently working to develop an updated National Strategic Plan (NSP) for 2021-2023. This new NSP is in line with the United Nations General Assembly (UNGA) High-Level Meeting on TB targets.


The following tables illustrate the distribution by technical area of the USAID TB budget for the Kyrgz Republic that will be used for the implementation of the Kyrgz Republic’s FY21 TB Roadmap (Table 1) and the core indicators that will be used to monitor implementation of the Kyrgz Republic’s TB Roadmap and the country's progress towards the United Nations General Assembly High-Level Meeting on TB targets (UNGA targets) (Table 2).

Table 1: USAID Budget for Kyrgyz Republic per Technical Area*

Technical Area USAID TB budget for FY21 USAID Percentage of TB budget for FY21
REACH $1,800,000 30%
CURE $2,350,000 39%
PREVENT $950,000 16%
SELF-RELIANCE $900,000 15%
TOTAL BUDGET: $6,000,000 100%

*USAID is working with the Global Fund to provide similar budget data for next year. It is anticipated this information will be added once the discussions have been finalized.

Table 2: TB Core Indicators in Kyrgyz Republic from 2015-2019 and Targets from 2020-2022

# Name 2015 2016 2017 2018 2019* 2020** 2021** 2022**
REACH: Increased DS- and DR-TB case notification
1 TB Detection 86.8% 86.7% 86.8% 86.8% 87% UNGA target: 6,900 UNGA target: 6,500 UNGA target: 6,300
2 Bacteriological Diagnosis Coverage (Pulmonary TB) 60.6% 57.7% 62.1% 61.3% 63%
3 Childhood TB Notifications 537 407 436 310 305 UNGA target: 300 UNGA target: 300 UNGA target: 300
4 Drug-Resistant TB Notifications 1,170 1,309 1,506 1,822 1,577 UNGA target: 1,740 UNGA target: 2,015 UNGA target: 2,290
5 Private Sector TB Notifications TBD
6 Contact Investigation Coverage*** 85% TBD
CURE: High treatment success rate in DS- and DR-TB
7 TB Treatment Success Rate 82.5% 81.8% 82.2% 81.0%
8 Drug-Resistant TB treatment Success Rate 52.2% 51.2% 55%
PREVENT: Prevent TB transmission and development
9 TPT Coverage 30 350 888 1,395 1,798 UNGA target: 4,070 UNGA target: 6,160 UNGA target: 7,570
SELF-RELIANCE: Commitment and sustainability
10 Proportion of Domestic Financing for TB 51.6% 49%

*Provisional data.
**Projected UNGA targets.
***Based on available data.

Tuesday, October 13, 2020 - 7:30am

Last updated: October 13, 2020